Herein, in a target-based study, we further examined the discovered compound’s mode of action in silico by considering the reference co-crystal structure of HDAC and its inhibitors and showed that the newly synthesized compounds could mimic HDACis in BC cells. The gene discussed is HDAC9; the disease is breast cancer.